NCT04030507View on ClinicalTrials.gov

Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer

NARecruitingINTERVENTIONAL

Enrollment

214

Participants

Timeline

Start Date

July 26, 2019

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2026

Conditions

Breast CancerHER2-positive Breast CancerTriple Negative Breast CancerHormone Receptor Positive Malignant Neoplasm of BreastInflammatory Breast CancerMetastatic Breast Cancer

Interventions

DEVICE

MRI

MRI (which stands for magnetic resonance imaging) provide imaging of the brain which help look for brain metastases (spread of the breast cancer to the brain).

Trial Locations (1)

02115

RECRUITING

Brigham and Women's Hospital, Boston

All Listed Sponsors

collaborator

Conquer Cancer Foundation

OTHER

lead

Dana-Farber Cancer Institute

OTHER

NCT04030507 - Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer | Biotech Hunter | Biotech Hunter